We are monitoring the impact of COVID-19 on MEA Capecitabine Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 6201
Share on
Share on

Middle East & Africa Capecitabine Market Research Report - Segmented By Application, Drug Formulation & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 6201
Pages: 145

MEA Capecitabine Market Size & Growth (2021 to 2026):

As per the research report, the size of the Middle East and Africa Capecitabine market was valued at USD XX Million in 2021 and is expected to reach USD XX Million by 2026 at XX% CAGR during the forecast period 2021 to 2026. 

Capecitabine is a chemotherapy drug used in the treatment of cancers such as gastric cancer, colorectal cancer, and breast cancer. It acts on the cancer cells and not only does it prevents them from further multiplying, buts also helps in destroying the cancer cells.

Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of capecitabine drive the growth of the capecitabine market. According to the National Cancer Institute around 135,430 people are estimated to suffer from colon and rectum cancer and 50,260 people died of colon and rectum cancer in 2019 in the U.S. Furthermore, rise in healthcare expenditure and increase in investment in cancer treatment or assisted programs by governments and private organizations such as Cancer Care and Cancer Suraksha Scheme are anticipated to boost the market growth. However, high cost of capecitabine, adverse effects, presence of substitutes, such as raltitrexed and leucovorin, and stringent government regulations related to the safety and efficacy of capecitabine hinder the market growth. Ongoing R&D activities related to capecitabine are anticipated to present new opportunities for the market.

This research report on the MEA Capecitabine Market has been segmented and sub-segmented into the following categories:

By Application:

  • Colon Cancer
  • Rectal Cancer
  • Breast Cancer
  • Gastric Cancer
  • Others

By Drug Formulation:

  • Tablets
  • Capsules

By Country:

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

On the basis of geography, the Capecitabine market is segmented into Middle East and Africa.

The leading companies leading in the MEA Capecitabine Market profiled in the report are Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Perrigo Company plc, Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation and Avita Medical Limited.

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods     

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Application                                                 

                                5.1.1 Introduction                                           

                                5.1.2 Colon Cancer                                          

                                5.1.3 Rectal Cancer                                         

                                5.1.4 Breast Cancer                                        

                                5.1.5 Gastric Cancer                                       

                                5.1.6 Others                                      

                                5.1.7 Y-o-Y Growth Analysis, By Application                                         

                                5.1.8 Market Attractiveness Analysis, By Application                                       

                                5.1.9 Market Share Analysis, By Application                                        

                5.2 Drug Formulation                                                     

                                5.2.1 Introduction                                           

                                5.2.2 Tablets                                      

                                5.2.3 Capsules                                  

                                5.2.4 Y-o-Y Growth Analysis, By Drug Formulation                                            

                                5.2.5 Market Attractiveness Analysis, By Drug Formulation                                          

                                5.2.6 Market Share Analysis, By Drug Formulation                                            

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Application                    

                                                6.1.3.3 By Drug Formulation                       

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Application                    

                                                6.1.4.3 By Drug Formulation                       

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Application                    

                                                6.1.5.3 By Drug Formulation                       

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Novartis AG                                                

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Sensus Healthcare                                                   

                8.3 RXi Pharmaceuticals Inc.                                                       

                8.4 Sonoma Pharmaceuticals Inc.                                                             

                8.5 Perrigo Company plc                                                              

                8.6 Bristol-Myers Squibb Company                                                         

                8.7 Pacific World Corporation                                                     

                8.8 Valeant Pharmaceuticals International Inc.                                                   

                8.9 Revitol Corporation                                                 

                8.10 Avita Medical Limited.                                                         

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Market Outlook and Investment Opportunities                                                                         

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Region, by Application along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Middle East and Africa Capecitabine  Market By Application, From 2021 to 2026 ( USD Million )
  2. Middle East and Africa Colon Cancer Market By Region, From 2021 to 2026 ( USD Million )
  3. Middle East and Africa Rectal Cancer Market By Region, From 2021 to 2026 ( USD Million )
  4. Middle East and Africa Breast Cancer Market By Region, From 2021 to 2026 ( USD Million )
  5. Middle East and Africa Gastric Cancer Market By Region, From 2021 to 2026 ( USD Million )
  6. Middle East and Africa Others Market By Region, From 2021 to 2026 ( USD Million )
  7. Middle East and Africa Capecitabine  Market By Drug Formulation, From 2021 to 2026 ( USD Million )
  8. Middle East and Africa Tablets Market By Region, From 2021 to 2026 ( USD Million )
  9. Middle East and Africa Capsules Market By Region, From 2021 to 2026 ( USD Million )
  10. Middle East Capecitabine  Market By Application, From 2021 to 2026 ( USD Million )
  11. Middle East Capecitabine  Market By Drug Formulation, From 2021 to 2026 ( USD Million )
  12. Africa Capecitabine  Market By Application, From 2021 to 2026 ( USD Million )
  13. Africa Capecitabine  Market By Drug Formulation, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample